|
|
Angelman Syndrome Complicated with Exotropia: A case Report |
Haiyun Ye,Jincai Feng,Siying Wang,Yuan Li,and Tong Qiao |
|
[1] |
Shaaya EA, Grocott OR, Laing O, et al. Seizure treatment in Angelman syndrome: A case series from the Angelman Syndrome Clinic at Massachusetts General Hospital. Epilepsy Behav, 2016,60: 138-141. DOI: 10.1016/j.yebeh.2016.04.030.
|
[2] |
Williams CA, Beaudet AL, Clayton-Smith J, et al. Angelman syndrome 2005: updated consensus for diagnostic criteria. Am J Med Genet A, 2006, 140(5): 413-418. DOI:10.1002/ajmg.a.31074.
|
[3] |
Williams CA, Driscoll DJ, Dagli AI. Clinical and genetic aspects of Angelman syndrome. Genet Med, 2010, 12(7): 385-395. DOI: 10.1097/GIM.0b013e3181def138.
|
[4] |
Michieletto P, Bonanni P, Pensiero S. Ophthalmic findings in Angelman syndrome. J AAPOS, 2011, 15(2): 158-161. DOI: 10.1016/j.jaapos.2010.12.013.
|
[5] |
Margolis SS, Sell GL, Zbinden MA, et al. Angelman syndrome.Neurotherapeutics, 2015, 12(3): 641-650. DOI: 10.1007/s13311-015-0361-y.
|
[6] |
Buiting K, Williams C, Horsthemke B. Angelman syndromeinsights into a rare neurogenetic disorder. Nat Rev Neurol, 2016,12(10): 584-593. DOI: 10.1038/nrneurol.2016, 133.
|
[7] |
Wilson BJ, Sundaram SK, Huq AH, et al. Abnormal language pathway in children with Angelman syndrome. Pediatr Neurol,2011, 44(5): 350-356. DOI:10.1016/j.pediatrneurol.2010.12.002.
|
[8] |
Santini E, Klann E. Genetically Dissecting Cortical Neurons Involved in Epilepsy in Angelman Syndrome. Neuron,2016, 90(1): 1-3. DOI: 10.1016/j.neuron.2016.03.023.
|
[9] |
Huang HS, Allen JA, Mabb AM, et al. Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons. Nature, 2011,481(7380): 185-189. DOI: 10.1038/nature10726.
|
[1] |
. [J]. Chinese Journal of Optometry Ophthalmology and Visual science, 2023, 25(8): 0-. |
|
|
|
|